Flex Pharma

FLKS NASDAQ
0.6054
-0.0216
-3.45%
Pre Market: 0.6299 +0.0245 +4.05% 04:39 07/19 EDT
Open
0.6300
Prev Close
0.6270
High
0.6400
Low
0.6015
Volume
1.22M
Avg Vol (3M)
1.16M
52 Week High
1.490
52 Week Low
0.2600
% Turnover
6.75%
Market Cap
10.94M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Flex Pharma FLKS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Flex Pharma, Inc. is a biotechnology company. The Company develops treatments for nocturnal leg cramps, muscle cramps and spasms associated with severe neuromuscular conditions, and exercise associated muscle cramps (EAMCs). The Company's product candidates activate certain receptors in primary sensory neurons, which then act through neuronal circuits to reduce the repetitive firing, or hyperexcitability, of alpha-motor neurons in the spinal cord, thereby preventing or reducing the frequency and intensity of muscle cramps and spasms. The Company operates through developing and commercializing products for nocturnal leg cramps, muscle cramps, spasms and spasticity associated with severe neuromuscular conditions, and exercise-associated muscle cramps segment. The Company's lead drug product candidate is FLX-787, which is in the Phase II clinical trial stage. It is developing a consumer brand and products specifically formulated to treat athletes suffering from EAMCs.
MORE >

Recently

Name
Price
%Change